IRIS UniCatt

Petito, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.638
AS - Asia 3.061
EU - Europa 2.892
SA - Sud America 611
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 10.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.508
SG - Singapore 1.395
CN - Cina 755
IT - Italia 656
DE - Germania 628
BR - Brasile 504
SE - Svezia 437
FR - Francia 278
VN - Vietnam 255
PL - Polonia 194
GB - Regno Unito 154
IN - India 110
UA - Ucraina 109
IE - Irlanda 108
FI - Finlandia 101
ID - Indonesia 89
HK - Hong Kong 88
JP - Giappone 76
TR - Turchia 68
CA - Canada 61
RU - Federazione Russa 61
AR - Argentina 41
MX - Messico 40
KR - Corea 36
BE - Belgio 34
NL - Olanda 34
BD - Bangladesh 31
ZA - Sudafrica 24
ES - Italia 22
IQ - Iraq 22
IR - Iran 20
EC - Ecuador 17
CO - Colombia 12
PK - Pakistan 12
VE - Venezuela 12
AT - Austria 11
EU - Europa 11
EG - Egitto 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
NP - Nepal 9
TN - Tunisia 9
CZ - Repubblica Ceca 8
AZ - Azerbaigian 7
CL - Cile 7
MA - Marocco 7
UZ - Uzbekistan 7
IL - Israele 6
JM - Giamaica 6
PE - Perù 6
PH - Filippine 6
PY - Paraguay 6
RO - Romania 6
CI - Costa d'Avorio 5
LT - Lituania 5
TH - Thailandia 5
AU - Australia 4
BH - Bahrain 4
CR - Costa Rica 4
HU - Ungheria 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
OM - Oman 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
KH - Cambogia 3
LV - Lettonia 3
MY - Malesia 3
NI - Nicaragua 3
PT - Portogallo 3
TW - Taiwan 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 10.272
Salva come PNG Salva come JPEG
Città #
Singapore 810
Chandler 463
San Jose 394
Ashburn 345
Beijing 193
Warsaw 165
Rome 122
Los Angeles 117
Cattolica 107
Dublin 107
New York 104
Ho Chi Minh City 90
Jacksonville 82
Lauterbourg 79
Jakarta 78
Ann Arbor 77
Hong Kong 73
The Dalles 65
Munich 64
Tokyo 63
Frankfurt am Main 62
Hanoi 61
São Paulo 60
Hefei 58
Milan 55
San Mateo 55
Boston 54
Wilmington 51
Nanjing 49
Dallas 48
Helsinki 46
Hangzhou 43
Houston 42
Izmir 38
Woodbridge 38
Moscow 36
Princeton 36
Marseille 35
Dearborn 34
Council Bluffs 31
Fairfield 31
London 30
Chicago 29
North Bergen 29
Nuremberg 29
Shanghai 29
Boardman 27
Brussels 27
Redwood City 27
Santa Clara 26
Seattle 26
Nürnberg 25
Seoul 25
Lawrence 23
Turku 23
Orem 21
Paris 21
Brooklyn 20
Buffalo 18
Nanchang 18
Stockholm 18
Guangzhou 17
Kent 17
Kraków 17
Lancaster 17
Shenyang 17
Atlanta 16
Bremen 16
Da Nang 16
Montreal 16
Redmond 16
Chennai 15
Johannesburg 15
Rio de Janeiro 15
St Louis 15
Toronto 15
Amsterdam 14
Mountain View 14
Phoenix 14
Mexico City 13
San Francisco 13
Tianjin 13
Zhengzhou 13
Augusta 12
Baghdad 12
Charlotte 12
Düsseldorf 12
Haiphong 12
Poplar 12
Pune 12
Cambridge 11
Denver 11
Fremont 11
Hyderabad 11
Kish 11
Manchester 11
Naples 11
Norwalk 11
Hebei 10
Mumbai 10
Totale 5.578
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 370
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 231
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 230
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 215
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 208
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 207
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 206
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 198
13C-octanoic acid breath test to study gastric emptying time 184
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 179
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 174
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 173
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 164
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 158
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 157
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 156
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 154
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 153
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 152
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 151
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 149
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 149
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 148
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 141
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 140
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 139
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 138
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 135
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 132
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 132
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 129
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 129
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 129
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma 129
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 127
An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients 126
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 126
Commensal Clostridia: leading players in the maintenance of gut homeostasis 125
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 125
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 125
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 124
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 123
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 122
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 121
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 120
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 120
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 120
Gut microbiota and inflammatory bowel disease: an update 119
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 113
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 111
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 110
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 108
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 106
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 105
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 105
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 104
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease 102
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer 101
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 101
Gut–joint axis: The role of physical exercise on gut microbiota modulation in older people with osteoarthritis 101
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 99
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 97
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 93
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 89
Bariatric procedures and microbiota: patient selection and outcome prediction 89
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 88
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 87
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 86
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 84
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 83
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 81
The Key Nutrients in the Mediterranean Diet and Their Effects in Inflammatory Bowel Disease: A Narrative Review 80
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 77
The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications 77
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis 73
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 71
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 71
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis 67
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 64
[Microbiota and inflammatory bowel disease: an update.] 63
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa 61
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 29
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study 13
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges 1
Totale 10.452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 0 81 21
2021/2022572 57 28 21 25 49 22 12 79 32 50 110 87
2022/20231.250 161 178 96 199 76 151 56 87 144 19 43 40
2023/2024780 46 176 29 43 32 101 49 27 43 34 85 115
2024/20251.646 42 45 136 54 143 69 86 71 225 177 321 277
2025/20264.212 627 119 262 570 808 234 667 221 308 341 55 0
Totale 10.452